Trial site
University of Massachusetts
Worcester, Massachusetts 01655, United StatesNot linked to an institution yet
- 16running trials
- 12closed trials
The trials here
What the 29 trials at this site are about, from their registry records.
- Phase
- Phase 38 trials
- Phase 25 trials
- Phase 2/31 trial
- Status
- Completed12 trials
- Active, not recruiting8 trials
- Recruiting6 trials
- Enrolling by invitation2 trials
- Suspended1 trial
- Lead sponsor
- Cerenovus, Part of DePuy Synthes Products, Inc.2 trials
- Mercy Health Ohio2 trials
- AbbVie1 trial
- Ancora Heart, Inc.1 trial
- Avita Medical1 trial
- and 22 more
Running trials
Enrolling by invitation
SafeHeal Colovac Anastomosis Protection Device Evaluation Pivotal Study
NCT07116668· SafeHeal Inc· Source
Recruiting
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
NCT07007312· Phase 3· Kura Oncology, Inc.· Source
Recruiting
Radiation Free Study
NCT06549348· Philips Clinical & Medical Affairs Global· Source
Contact: Andres Schanzer (principal investigator)
Active, not recruiting
Evaluation of D-Fi for the Treatment of Wounds Due to DEB
NCT06892639· Phase 3· Castle Creek Biosciences, LLC.· Source
Enrolling by invitation
A Community Health Worker/Pharmacist Team to Improve Blood Sugars in Diabetes Care Using Continuous Glucose Monitoring
NCT05911256· University of Massachusetts, Worcester· Source
Recruiting
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial
NCT05611242· Phase 3· Mercy Health Ohio· Source
Contact: Noelle Bodkin
Recruiting
Zenith® Fenestrated+ Clinical Study
NCT04875429· Cook Research Incorporated· Source
Contact: Andres Schanzer, MD
Recruiting
Nectero EAST System Clinical Study
NCT06001918· Phase 2/3· Nectero Medical, Inc.· Source
Contact: Shauneen Valliere
Active, not recruiting
A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus
NCT04961567· Phase 3· Biogen· Source
Active, not recruiting
Abemaciclib and Letrozole to Treat Endometrial Cancer
NCT04393285· Phase 2· Gynecologic Oncology Group· Source
Active, not recruiting
A Phase 2 Study of Mirvetuximab Soravtansine (IMGN853) and Pembrolizumab in Endometrial Cancer (EC)
NCT03835819· Phase 2· Dana-Farber Cancer Institute· Source
Recruiting
Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer
NCT03659448· Phase 3· Surgimab· Source
Contact: Sharon Balcom, RN
Active, not recruiting
ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement
NCT03735667· Boston Scientific Corporation· Source
Active, not recruiting
A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer
NCT03574571· Phase 3· Memorial Sloan Kettering Cancer Center· Source
Active, not recruiting
Multicenter Phase II Study of Transanal TME (taTME)
NCT03144765· Icahn School of Medicine at Mount Sinai· Source
Recruiting
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
NCT01351545· Center for International Blood and Marrow Transplant Research· Source
Contact: Elizabeth Fosberg, B.A.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Closed trials
Completed
A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Patients
NCT06292923· Phase 2· Tiziana Life Sciences LTD· Source
Completed
Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells
NCT05971381· Avita Medical· Source
Completed
Ph2, Study to Assess the Safety and Efficacy of GPC 100 and Propranolol With and Without G-CSF for the Mobilization of Stem Cells in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant
NCT05561751· Phase 2· GPCR Therapeutics, Inc.· Source
Completed
A Randomized, Controlled Trial to Evaluate the Safety and Effectiveness of the Route 92 Medical Reperfusion System (SUMMIT MAX)
NCT05018650· Route 92 Medical, Inc.· Source
Completed
Study With Afuresertib and Paclitaxel in Platinum Resistant Ovarian
NCT04374630· Phase 2· Laekna Limited· Source
Completed
A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression
NCT04209855· Phase 3· AbbVie· Source
Completed
The TESLA Trial: Thrombectomy for Emergent Salvage of Large Anterior Circulation Ischemic Stroke
NCT03805308· Mercy Health Ohio· Source
Completed
Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced, Unresectable Pancreatic Cancer
NCT03941093· Phase 3· Kyntra Bio· Source
Completed
Alcoholic Hepatitis Network Observational Study
NCT03850899· Indiana University· Source
Completed
CERENOVUS Neurothrombectomy Devices Registry
NCT03685578· Cerenovus, Part of DePuy Synthes Products, Inc.· Source
Completed
A Study to Look at Performance of MICRUSFRAME and GALAXY Coils for the Treatment of Intracranial Aneurysms
NCT03642639· Cerenovus, Part of DePuy Synthes Products, Inc.· Source
Completed
Clinical Study of the Treovance Stent-Graft for Patients With Abdominal Aortic Aneurysms
NCT02009644· Bolton Medical· Source
Report an error